Bovine VLP-1 antibody and antigen (recombinant protein)

Diagnostic anti-Bovine VLP-1 antibodies pairs and antigen for animal health (animal Bovines/Cattle Alzheimer Disease(AD)) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT

Target products collectionGo to Neurodegenerative diseases diagnostics products collection >>


Product information

Catalog No. Description US $ Price (per mg)
GMP-BOV-VLP-1-Ag01 Recombinant Bovine VLP-1 protein 3090
GMP-BOV-VLP-1-Ab01 Anti-Bovine VLP-1 mouse monoclonal antibody (mAb) 1953
GMP-BOV-VLP-1-Ab02 Anti-Bovine VLP-1 mouse monoclonal antibody (mAb) 1953
GMP-BOV-VLP-1-Ab03 Anti-Bovine VLP-1 human monoclonal antibody (mAb) 1953
GMP-BOV-VLP-1-Ab04 Anti-Bovine VLP-1 human monoclonal antibody (mAb) 1953

Size: 1mg | 10mg | 100mg



Product Description

Cat No. of Products GMP-BOV-VLP-1-Ag01
Product Name Recombinant Bovine VLP-1 protein
Target/Biomarker Bovine Visinin-Like Protein 1 (VLP-1)
Expression platform E.coli
Isotypes Recombinant Antigen
Bioactivity validation Anti-Bovine Visinin-Like Protein 1 antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in VLP-1 level test of animal Bovines/Cattle with Alzheimer Disease(AD).
Tag His
Products description Recombinant Bovine VLP-1 protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products GMP-BOV-VLP-1-Ab01, GMP-BOV-VLP-1-Ab02
Product Name Anti-Bovine VLP-1 mouse monoclonal antibody (mAb)
Target/Biomarker Bovine Visinin-Like Protein 1 (VLP-1)
Expression platform CHO
Isotypes Mouse IgG
Bioactivity validation Recombinant Bovine Visinin-Like Protein 1 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-VLP-1 antibodies in VLP-1 level test of animal Bovines/Cattle with Alzheimer Disease(AD).
Tag mFc
Products description Anti-Bovine VLP-1 mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-VLP-1 antibodies.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products GMP-BOV-VLP-1-Ab03, GMP-BOV-VLP-1-Ab04
Product Name Anti-Bovine VLP-1 human monoclonal antibody (mAb)
Target/Biomarker Bovine Visinin-Like Protein 1 (VLP-1)
Expression platform CHO
Isotypes Human IgG1
Bioactivity validation Recombinant Bovine Visinin-Like Protein 1 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-VLP-1 antibodies in VLP-1 level test of animal Bovines/Cattle with Alzheimer Disease(AD).
Tag hFc
Products description Anti-Bovine VLP-1 human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-VLP-1 antibodies.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Validation Data


    Click to get more Data / Case study about the product.



    Target/Biomarker information

    Bovine Vaccinia-Like Particles-1 (VLP-1) occupies a fascinating niche within the intricate fabric of bovine immunology. At its core, VLP-1 is a unique molecular structure, bearing a striking resemblance to certain viral particles while being devoid of the genetic material required for viral replication. Structurally, it primarily comprises protein subunits that encapsulate fragments of bovine DNA. VLP-1 assumes a pivotal role in the bovine immune response, especially in the context of viral infections and vaccinations. When cattle encounter viral pathogens or receive vaccines, their immune system triggers a coordinated defense. Part of this elaborate defense involves the synthesis and release of VLP-1 by immune cells. This biomarker serves as a molecular beacon, signaling the activation of the immune system, particularly in response to viral antigens. It is important to underline that VLP-1 does not induce illness; rather, it amplifies the bovine immune response. Its virus-like appearance acts as a catalyst, igniting a robust immunological reaction. This process primes the bovine immune system, preparing it to recognize and combat actual viral threats with heightened precision and potency. It forms the foundation of the body's defense against viral adversaries.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.

    Comments


    No comments yet.

    Leave a comment